By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Otsuka Pharmaceutical Co., Ltd. 

2-9 Kanda Tsukasa-cho
Tokyo    101-8535  Japan
Phone: 03-3292-0021 Fax:



Company News
Otsuka Pharma And Proteus Digital Health Resubmit Application To FDA For First Digital Medicine 5/23/2017 9:14:56 AM
Otsuka Pharma Announces Results Of Phase III Data On Tolvaptan 5/22/2017 7:28:47 AM
Otsuka Pharma And Teva (TEVA) Sign Licensing Agreement For Japan On Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125) 5/15/2017 9:06:10 AM
Otsuka Pharma Release: Launch Of Alzheimer’s Journey Coordinator Certificate Program 5/10/2017 9:12:14 AM
Mixed Data For Alzheimer’s-Type Dementia Drug Leave Lundbeck (LUN.CO), Otsuka Pharma Investors Unsettled 5/2/2017 6:52:45 AM
Otsuka Pharma And Lundbeck (LUN.CO) Announce Results Of Brexpiprazole On Symptoms Of Agitation Related To Alzheimer’s-Type Dementia 5/2/2017 6:52:20 AM
Why Akebia (AKBA), Even With Otsuka Pharma's Big Deal, May Need To Be Acquired 4/27/2017 7:07:32 AM
Otsuka Pharma Believes in Akebia (AKBA), Commits Another $865 Million to Expand Anemia Deal 4/26/2017 5:38:54 AM
Otsuka Pharma Plunks Down $250 Million for Cambridge Biotech Neurovance for Late-Stage Ready ADHD Drug 3/3/2017 7:32:13 AM
Health Canada Approves Otsuka Pharma And Lundbeck (LUN.CO)'s REXULTI (Brexpiprazole) As A Treatment For Schizophrenia In Adults 2/20/2017 6:37:22 AM